PhD Candidate, Tongji Medical College, Huazhong University of Science and Technology, Medical Imaging and Nuclear Medcine, 2008-Present
MD, Tongji Medical College, Huazhong University of Science and Technology, Clinical Medicine, 2008
Molecular Imaging Program at Stanford
Canary Center at Stanford for Cancer Early Detection
1501 S. California Avenue
MC 5539 / Room 2118A
Palo Alto, California 94304
Phone: (650) 724-0495
Basic researches mainly focus on multimodality molecular imaging and reporter gene for non-invasive cancer early detection and potential treatment.
- Chunxia Qin, MD, Cao Wei, PhD, Yongxue Zhang, MD, Fabian Pius Mghanga, MD, Xiaoli Lan, PhD, Zairong Gao, PhD, and Rui An, PhD. Correlation of Clinicopathological Features and Expression of Molecular Markers With Prognosis After I-131 Treatment of Differentiated Thyroid Carcinoma. Clinical Nuclear Medicine. 2011; Accepted.
- QIN Chun-xia, LAN Xiao-li, ZHANG Yong-xue. Progress in PET/MRI multimodality molecular imaging. Int J Radiat Med Nucl Med. 2011; 35(4): 207-212. Chunxia Qin, Xiaoli Lan*, Jiang He, Xiaotian Xia, Yueli Tian, Zhijun Pei, Yongxue Zhang*. An in vitro and in vivo evaluation of the novel reporter gene/probe system hERL/18F-FES. 2011. Submitted.
- Zhijun Pei, Xiaoli Lan, Chunxia Qin, Jia Hu, and Yongxue Zhang. Study of multimodality molecular imaging with a triple-fused reporter gene. J Nucl Med. MEETING ABSTRACTS, 2011;52 (supple):1610.
- Chunxia Qin, Wei Cao, Xiaoli Lan, Yongxue Zhang, et al. Analysis of the Curative Effect of 131I Therapy for Hyperthyroidism and the Influencing Factors. Acta Med Univ Sci Technol Huazhong. 2010;39(6):845-850.